AJMC ® Peer Exchange™ provides a multi-stakeholder perspective on important issues facing managed care professionals in the evolving health care landscape. Psoriasis is a high-cost disease state in ...

STEPIn enrolled systemic- and phototherapy-naïve adults with plaque psoriasis ≤1 year and randomized secukinumab 300 mg versus nb-UVB for 52 weeks, then observed off-treatment to week 104. Off-therapy ...

Studies have suggested that psoriasis is an independent risk factor for heart attack in the general population, but investigators have made the surprising finding that in people who also have ...

The use of GLP-1 RAs may be appropriate among select patients with psoriasis, although additional research is needed to guide ...

Patients with type 2 diabetes (T2D) who have psoriasis showed an increased risk for renal disease, including diabetic neuropathy, chronic kidney disease (CKD), end-stage renal disease (ESRD), and ...

Like other inflammatory conditions, psoriasis often comes with concurrent systemic comorbidities, and physicians should be aware of symptoms that suggest associated conditions. Comorbidities include ...

Beneath and beyond the reddish, flaky lesions that form in the skin of those with psoriasis, mild and severe forms of the disease can be told apart by the activity of key cells and signaling pathways, ...

Some psoriasis treatments may modify the underlying disease in ways that go beyond their direct pharmacological effects. The controversial idea of disease modification is the subject of a review that ...

The National Psoriasis Foundation (NPF) welcomed more than 175 supporters, advocates, and leaders in health care and industry to its annual Southeast Soirée on May 7, 2026. The inspiring evening ...

Please provide your email address to receive an email when new articles are posted on . Patients with moderate to severe psoriasis were 2.68 times more likely to take a half-day or more from work vs.